SG11201911826VA - Therapeutic agent for aspiration pneumonia, lung suppuration, or lung abscess - Google Patents

Therapeutic agent for aspiration pneumonia, lung suppuration, or lung abscess

Info

Publication number
SG11201911826VA
SG11201911826VA SG11201911826VA SG11201911826VA SG11201911826VA SG 11201911826V A SG11201911826V A SG 11201911826VA SG 11201911826V A SG11201911826V A SG 11201911826VA SG 11201911826V A SG11201911826V A SG 11201911826VA SG 11201911826V A SG11201911826V A SG 11201911826VA
Authority
SG
Singapore
Prior art keywords
lung
therapeutic agent
suppuration
aspiration pneumonia
abscess
Prior art date
Application number
SG11201911826VA
Inventor
Masaaki Odajima
Sayoko Tanioka
Takaaki Sunouchi
Asako Tabuchi
Original Assignee
Kyorin Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyorin Pharmaceutical Co Ltd filed Critical Kyorin Pharmaceutical Co Ltd
Priority claimed from PCT/JP2018/022846 external-priority patent/WO2018230686A1/en
Publication of SG11201911826VA publication Critical patent/SG11201911826VA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
SG11201911826VA 2017-06-16 2018-06-15 Therapeutic agent for aspiration pneumonia, lung suppuration, or lung abscess SG11201911826VA (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762520961P 2017-06-16 2017-06-16
JP2018068159 2018-03-30
PCT/JP2018/022846 WO2018230686A1 (en) 2017-06-16 2018-06-15 Therapeutic agent for aspiration pneumonia, lung suppuration, or lung abscess

Publications (1)

Publication Number Publication Date
SG11201911826VA true SG11201911826VA (en) 2020-01-30

Family

ID=66213244

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201911826VA SG11201911826VA (en) 2017-06-16 2018-06-15 Therapeutic agent for aspiration pneumonia, lung suppuration, or lung abscess

Country Status (14)

Country Link
US (1) US20210137913A1 (en)
EP (1) EP3639826A4 (en)
JP (3) JP6618660B2 (en)
KR (1) KR20200016960A (en)
CN (1) CN110891571A (en)
AU (1) AU2018283234A1 (en)
BR (1) BR112019025960A2 (en)
CA (1) CA3067188A1 (en)
CL (1) CL2019003630A1 (en)
IL (1) IL270831A (en)
MX (1) MX2019014931A (en)
PH (1) PH12019502835A1 (en)
SG (1) SG11201911826VA (en)
TW (1) TWI818910B (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19962470A1 (en) * 1999-12-22 2001-07-12 Schulz Hans Herrmann Use of chemotherapy drugs
CN100410249C (en) 2003-09-10 2008-08-13 杏林制药株式会社 7-(4-substituted 3- cyclopropylaminomethyl-1- pyrrolidinyl) Q uinolonecarboxylic acid derivative
SA112330992B1 (en) 2011-11-10 2015-09-13 كيورين فارماسوتيكال كو.، ليمتد Crystalline form of the 7-{(3S,4S)-3 [(cyclopropylamino)methyl]-4- fluoropyrrolidine-1-YL}-6-fluoro-1-(2-fluoroethyl)-8-methoxy-4-OXO- 1,4-dihydroquinoline-3-carboxylic acid
EA201791995A1 (en) * 2015-03-13 2017-12-29 Керин Фармасьютикал Ко., Лтд. MEANS FOR THE TREATMENT OF RESPIRATORY INFECTION
WO2016195014A1 (en) 2015-06-02 2016-12-08 杏林製薬株式会社 Aqueous drug

Also Published As

Publication number Publication date
IL270831A (en) 2020-01-30
KR20200016960A (en) 2020-02-17
JP2020079330A (en) 2020-05-28
EP3639826A1 (en) 2020-04-22
EP3639826A4 (en) 2021-03-03
CN110891571A (en) 2020-03-17
JPWO2018230686A1 (en) 2019-12-12
CL2019003630A1 (en) 2020-07-10
AU2018283234A1 (en) 2019-12-12
PH12019502835A1 (en) 2020-10-05
MX2019014931A (en) 2020-02-13
JP6618660B2 (en) 2019-12-11
JP2020015769A (en) 2020-01-30
JP6671532B2 (en) 2020-03-25
TW201906607A (en) 2019-02-16
JP7098671B2 (en) 2022-07-11
US20210137913A1 (en) 2021-05-13
BR112019025960A2 (en) 2020-11-03
TWI818910B (en) 2023-10-21
CA3067188A1 (en) 2018-12-20

Similar Documents

Publication Publication Date Title
GB2575371B (en) Zoned exhaust system
GB2557088B (en) Blower
EP3232131A4 (en) Air-conditioning system
EP2959918A4 (en) Anti-malignant tumor agent composition
EP3388088A4 (en) Air purifying agent composition
GB201600513D0 (en) Compact ventilation system
PL3338032T3 (en) Air treatment system
SG11201802965UA (en) Air conditioning system
EP3339765A4 (en) Air-conditioning system
GB201602315D0 (en) Indoor location system
HK1254239A1 (en) Novel aminoglycoside antibiotic effective against multidrug-resistant bacteria
GB201516458D0 (en) Air conditioning system
EP3302478A4 (en) Pac-1 combination therapy
EP3370005A4 (en) Air-conditioning system
GB2550723B (en) Air-conditioning system
GB2553072B (en) Blowing agent
GB201516460D0 (en) Ventilation system
EP3452052A4 (en) Agent delivery system
EP3369430A4 (en) Acute respiratory distress syndrome therapeutic agent
GB201503026D0 (en) Breathing air system
IL253878A0 (en) Respiratory infection treating agent
IL270831A (en) Therapeutic agent for aspiration pneumonia, lung suppuration, or lung abscess
EP3362545A4 (en) Multi-stage benefit agent delivery system
HK1210573A2 (en) Air ventilation system
GB201503306D0 (en) Ventilator system